Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history and the previous revision v3.4.2 was removed. The page's version history was updated accordingly.
    Difference
    0.1%
    Check dated 2026-03-11T15:14:57.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Version history now includes Revision: v3.4.2 added, and the notices about government funding and the earlier Revision: v3.4.1 have been removed. These are administrative updates that do not change study data or user-facing functionality.
    Difference
    0.7%
    Check dated 2026-02-11T02:07:44.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A site-wide funding notice about potential delays in updates was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-03T22:37:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The history page now includes a glossary display option, and changes are shown with green highlights for additions and red highlights for deletions. The revision line shows v3.4.0 and the No FEAR Act Data item appears in the record.
    Difference
    1.0%
    Check dated 2026-01-27T17:24:29.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The record history shows a new revision (v3.3.4) replacing the prior (v3.3.3), a minor administrative update that does not alter study content or results; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-20T13:54:57.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the history, and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-22T20:47:53.000Z thumbnail image

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.